|
|
 |
|
Viewing report
|
|
|
|
RNAi: Product Usage and Brand Assessment
BioInformatics, LLC, Oct 2010
Since the 2006 award of the Nobel Prize in Physiology or Medicine went to Fire and Mello for their discovery of RNA interference (RNAi), the deployment of (RNAi) has taken a major leap. RNAi, or gene silencing, is a system within cells that enables the control and regulation of active genes that can be exploited by scientists for various technological applications. The precise and lasting effects of RNAi on gene expression makes it a uniquely valuable research tool and a potentially powerful solution for biotechnology and medicine.
As scientists gain a greater understanding of RNAi capabilities and limitations, and as the RNAi market continues to grow rapidly, more varied RNAi products and selections are becoming commercially available. Whether they use siRNA, shRNA, or miRNA molecules, scientists that perform RNAi experiments rely on the ability to purchase various RNAi products and delivery systems from major life science suppliers as well as specialized RNAi companies.
The report, RNAi: Product Usage and Brand Assessment offers life science suppliers insights as how to maximize revenues from the types of products and services that support RNAi experiments. This report helps target areas of rapid growth in the RNAi market i.e., research focuses, cell types and/or model systems used, various small RNA types and how they are generated, RNAi delivery systems and methods for measuring gene expression levels. Market share and projections by market segment/top suppliers are included, along with RNAi research budget data and expected changes through 2012.
Additionally, this report details the competitive dynamics and opportunities in this exciting segment of the life science market. Respondents reveal the supplier attributes that are of greatest importance, and detail areas where suppliers perform above or below expectations. For the leading RNAi suppliers, this analysis goes a step further by assessing less tangible, but critically important, elements of customer value including attitudinal measurements such as overall customer experience, intent to re-purchase and willingness to recommend as well as behavioral measurements such as frequency of purchases and customer retention.
RNAi: Product Usage and Brand Assessment will provide RNAi product suppliers with critical insights into customer perceived concerns and needs with RNAi products and delivery systems. Growth opportunities are presented with the knowledge of customer preferred RNAi products and their design along with desired RNAi product improvements. By using this report, RNAi product suppliers will gain an understanding of where scientists predict the future direction of RNAi technologies is going and can better anticipate current and future RNAi product needs.
OBJECTIVES:
From the perspective of pharmaceutical, biotech and academic scientists who use RNAi products in their research, the primary objectives of this report are as follows:
- Assess the usage of various RNAi products, including siRNA, miRNA and shRNA
- Estimate average lab budgets for RNAi products, and predicted growth in FY2011 and FY2012
- Measure brand awareness and brand usage of siRNA, miRNA and shRNA products
- Gauge satisfaction with current RNAi technologies
- Understand perceived drawbacks and challenges of using RNAi technologies, and predicted future trends of RNAi technologies
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
RNAi - Technologies, Markets and Companies
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
2010 Gene Silencing Dashboard Series 3
RNA interference (RNAi) - Global Strategic Business Report
Gene Silencing Life Science Dashboard Series 2
Antiviral Therapeutics - Technologies, Markets and Companies
MicroRNA Analysis in North America: Trends & Opportunities in Early Growth Markets
Gene Therapy - Technologies, Markets and Companies
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
Nanobiotechnology Applications, Markets and Companies
|
|
|
|
